Compound ID | 1039
Class: Beta-lactam (cephalosporin)
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | Binding of PBP |
Institute where first reported: | Smith Kline and French Laboratories |
Year first mentioned: | 1974 |
Highest developmental phase: | Preclinical |
Development status: | Inactive |
Chemical structure(s): | |
Canonical SMILES: | CN1C(=NN=N1)SCC2=C(C(=O)O)N3C(=O)[C@H]([C@H]3SC2)NC(=O)CSC(F)(F)F |
Isomeric SMILES: | CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)CSC(F)(F)F)SC2)C(=O)O |
InChI: | InChI=1S/C13H13F3N6O4S3/c1-21-12(18-19-20-21)28-3-5-2-27-10-7(9(24)22(10)8(5)11(25)26)17-6(23)4-29-13(14,15)16/h7,10H,2-4H2,1H3,(H,17,23)(H,25,26)/t7-,10-/m1/s1 |
InChI Key: | HGXLJRWXCXSEJO-GMSGAONNSA-N |
Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/40240 |
External links: | |
Guide to Pharmacology: | cefazaflur |
Citation: | https://www.ncbi.nlm.nih.gov/pubmed/324399 |